Jihong Liu

5PUBLICATIONS
32CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 29, 2025
Optimal timing of primary debulking surgery in advanced ovarian cancer: insights from the TRUST trial.

Tingyan Shi, Yulian Chen, Rong Jiang

|Aug 16, 2021
Perineural Invasion Should Be Regarded as an Intermediate-Risk Factor for Recurrence in Surgically Treated Cervical Cancer: A Propensity Score Matching Study.

Ting Wan, Hua Tu, Lili Liu

|Jun 04, 2021
Sentinel lymph Node mapping versus systematic pelvic lymphadenectomy on the prognosis for patients with intermediate-high-risk Endometrial Cancer confined to the uterus before surgery: trial protocol for a non-inferiority randomized controlled trial (SNEC trial).

Jun Guan, Yu Xue, Rong Yu Zang

|Aug 19, 2020
Study of upfront surgery versus neoadjuvant chemotherapy followed by interval debulking surgery for patients with stage IIIC and IV ovarian cancer, SGOG SUNNY (SOC-2) trial concept.

Rong Jiang, Jianqing Zhu, Jae Weon Kim

|Oct 11, 2019
Comparison of PARPis with Angiogenesis Inhibitors and Chemotherapy for Maintenance in Ovarian Cancer: A Network Meta-Analysis.

Yanling Feng, He Huang, Ting Wan

Pageof 1

Frequent Collaborators

3 joint publications

Rongyu Zang

3 joint publications

Jianqing Zhu

2 joint publications

Libing Xiang

2 joint publications

Yanling Feng